Biblio
Export 644 results:
Author Title [ Type] Year Filters: First Letter Of Last Name is N [Clear All Filters]
“Three VCP Mutations in Patients with Frontotemporal Dementia.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1139-1146, 2018.
, “A Three-Factor Structure of Cognitive Functioning Among Unimpaired Carriers and Non-Carriers of Autosomal-Dominant Alzheimer's Disease.”, J Alzheimers Dis, vol. 65, no. 1, pp. 107-115, 2018.
, “Time trends in antipsychotic drug use in patients with dementia: a nationwide study.”, J Alzheimers Dis, vol. 49, no. 1, pp. 211-20, 2016.
, “Tocotrienol-Rich Fraction Modulates Amyloid Pathology and Improves Cognitive Function in AβPP/PS1 Mice.”, J Alzheimers Dis, vol. 55, no. 2, pp. 597-612, 2017.
, “Tocotrienol-Rich Fraction of Palm Oil Improves Behavioral Impairments and Regulates Metabolic Pathways in AβPP/PS1 Mice.”, J Alzheimers Dis, vol. 64, no. 1, pp. 249-267, 2018.
, “Tocotrienol-Rich Fraction of Palm Oil Improves Behavioral Impairments and Regulates Metabolic Pathways in AβPP/PS1 Mice.”, J Alzheimers Dis, vol. 64, no. 1, pp. 249-267, 2018.
, “Total MRI Small Vessel Disease Burden Correlates with Cognitive Performance, Cortical Atrophy, and Network Measures in a Memory Clinic Population.”, J Alzheimers Dis, vol. 63, no. 4, pp. 1485-1497, 2018.
, “Tract-Specific Correlates of Neuropsychological Deficits in Patients with Subcortical Vascular Cognitive Impairment.”, J Alzheimers Dis, vol. 50, no. 4, pp. 1125-35, 2016.
, “Traffic-Related Air Pollution as a Risk Factor for Dementia: No Clear Modifying Effects of APOEɛ4 in the Betula Cohort.”, J Alzheimers Dis, vol. 71, no. 3, pp. 733-740, 2019.
, “Trajectories of Physiological Brain Aging and Related Factors in People Aged from 20 to over-80.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1237-1246, 2018.
, “Transcriptome Changes in the Alzheimer's Disease Middle Temporal Gyrus: Importance of RNA Metabolism and Mitochondria-Associated Membrane Genes.”, J Alzheimers Dis, vol. 70, no. 3, pp. 691-713, 2019.
, “Traumatic Brain Injury and Age of Onset of Dementia with Lewy Bodies.”, J Alzheimers Dis, vol. 66, no. 2, pp. 717-723, 2018.
, “Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.”, N Engl J Med, vol. 370, no. 4, pp. 322-33, 2014.
, “Two Year Outcomes, Cognitive and Behavioral Markers of Decline in Healthy, Cognitively Normal Older Persons with Global Deterioration Scale Stage 2 (Subjective Cognitive Decline with Impairment).”, J Alzheimers Dis, vol. 67, no. 2, pp. 685-705, 2019.
, “Ultra-High Field MRI in Alzheimer's Disease: Effective Transverse Relaxation Rate and Quantitative Susceptibility Mapping of Human Brain In Vivo and Ex Vivo Compared to Histology.”, J Alzheimers Dis, vol. 73, no. 4, pp. 1481-1499, 2020.
, “The Uniform Data Set, Czech Version: Normative Data in Older Adults from an International Perspective.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1233-1240, 2018.
, “Unstable Body Mass Index and Progression to Probable Alzheimer's Disease Dementia in Patients with Amnestic Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 49, no. 2, pp. 483-91, 2016.
, “Unstable Body Mass Index and Progression to Probable Alzheimer's Disease Dementia in Patients with Amnestic Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 49, no. 2, pp. 483-91, 2016.
, “Upregulation of Thioredoxin-Interacting Protein in Brain of Amyloid-β Protein Precursor/Presenilin 1 Transgenic Mice and Amyloid-β Treated Neuronal Cells.”, J Alzheimers Dis, vol. 72, no. 1, pp. 139-150, 2019.
, “Urine-Based Biomarkers for Alzheimer's Disease Identified Through Coupling Computational and Experimental Methods.”, J Alzheimers Dis, vol. 65, no. 2, pp. 421-431, 2018.
, “The Utility of the Cognitive Function Instrument (CFI) to Detect Cognitive Decline in Non-Demented Older Adults.”, J Alzheimers Dis, vol. 60, no. 2, pp. 427-437, 2017.
, “Utility of the LIBRA Index in Relation to Cognitive Functioning in a Clinical Health Seeking Sample.”, J Alzheimers Dis, vol. 62, no. 1, pp. 373-384, 2018.
, “Validation by Magnetic Resonance Imaging of the Diagnostic Potential of a Heptapeptide-Functionalized Imaging Probe Targeted to Amyloid-β and Able to Cross the Blood-Brain Barrier.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1547-1565, 2017.
, “Validation of a Latent Construct for Dementia in a Population-Wide Dataset from Singapore.”, J Alzheimers Dis, vol. 55, no. 2, pp. 823-833, 2017.
, “Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort.”, J Alzheimers Dis, vol. 74, no. 1, pp. 213-225, 2020.
,